NRXP NRX PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2023 - Amendment to Convertible Promissory Note NRX Pharmaceuticals, Inc. entered into a Second Amendment to Convertible Promissory Note with Streeterville Capital, LLC, amending the redemption provisions of the note.Get access to all SEC 8-K filings of the NRX PHARMACEUTICALS INC